Nasdaq, Inc.: Delisting of Securities from The Nasdaq Stock Market
Nasdaq, Inc. said it will delist multiple securities that have been suspended and not traded on Nasdaq since late 2025 through July 2026, including common stock and warrants of CERo Therapeutics Holdings, Captivision Inc., Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, and others. The announcement cites Nasdaq delisting rules.
How this was made
The 30-second read
Why it matters
This is a venue-access and liquidity shock. Even if trading has been halted for a long period, the formal delisting announcement can affect remaining holders, derivatives/warrants, and any attempts to re-list or trade elsewhere.
Market read
Delisting announcements can drive forced repositioning, wider spreads, and valuation resets for affected equity and warrant holders.
What to watch
Traders should check whether securities transition to OTC or other venues, which can change liquidity and spread dynamics beyond the delisting headline.
Background
Nasdaq states it will delist multiple issuers whose securities were suspended and have not traded on Nasdaq since late 2025 through early July 2026.
Ticker impact
Nasdaq will delist Actelis Networks’ common stock after suspension and no trading since Apr 10, 2026.
Downward pressure and reduced liquidity are likely into the delisting effective date.
The article directly announces delisting of Actelis Networks’ common stock after it has not traded on Nasdaq since Apr 10, 2026.
Nasdaq announced delisting of American Rebel Holdings’ common stock and warrants after suspension and no trading since May 13, 2026.
Likely negative repricing and higher volatility around delisting.
The body states Nasdaq will delist the securities and that they have not traded on Nasdaq since the suspension date.
Nasdaq will delist Reviva Pharmaceuticals Holdings’ common stock after suspension and no trading since May 14, 2026.
Potential further decline and wider spreads as delisting approaches.
The article explicitly announces delisting and notes the stock has not traded on Nasdaq since May 14, 2026.
Nasdaq will delist REE Automotive Ltd.’s Class A ordinary shares after suspension and no trading since Jul 7, 2026.
Potential immediate downside and volatility as delisting approaches.
The article explicitly announces delisting of REE Automotive’s Class A ordinary shares after suspension and no trading since Jul 7, 2026.
Market effects
Broad delisting announcements highlight ongoing Nasdaq listing compliance stress among smaller-cap issuers.
Primarily impacts US-listed small caps and their liquidity, with potential spillover to OTC trading volumes.
Limited global read-through, but foreign issuers listed on Nasdaq face similar venue risk.
Counterpoint
If these names already stopped trading for months, incremental price impact may be limited versus the earlier suspension.
Key entities
- venueThe Nasdaq Stock Market
Announced delisting of multiple issuers’ securities after prolonged suspension and no trading.
